PerpEquities

Guardant Health, Inc. (GH) income statement

NASDAQ · Healthcare · Medical - Diagnostics & Research · 2,498 employees · CEO Helmy Eltoukhy

Price
$145.83 +0.16%
Market cap
$19.7B
Enterprise value
$20.4B Data as of 2026-11-22
Last report
Q3 '26 filed 2026-11-05
Next report
2027-02-18 EPS est. -$0.75

Guardant Health, Inc. (GH) reported revenue of $361M for Q3 '26 (+36.1% year on year), operating income of -$133M (-36.8% of revenue) and net income of -$124M. Over the last four quarters revenue was $1.28B.

Income statement

Income statementTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Revenue$155M$168M$177M$191M$202M$203M$232M$265M$281M$302M$335M$361M
Cost of revenue$62.5M$65.3M$72.4M$74.5M$77.6M$74.7M$81.2M$93.6M$99.5M$105M$116M$125M
Gross profit$92.5M$103M$105M$117M$124M$129M$151M$172M$182M$197M$219M$236M
Research & development$89.9M$83.8M$83.1M$87.3M$93.5M$88.5M$87.4M$90M$98.3M$91M$96.5M$101M
Sales & marketing$79.1M$80.4M$81.9M$97.9M$105M$104M$120M$127M$143M$169M$190M$177M
General & administrative$37.7M$38.7M$40.5M$49.1M$51.9M$47M$50.3M$53.3M$60.9M$57.9M$61.7M$90.9M
Other operating expenses$83.4M$0$0$0$0$0$0$0$0$0$0$0
Operating expenses$290M$203M$205M$234M$250M$240M$257M$271M$303M$318M$348M$369M
Operating income-$198M-$99.7M-$101M-$117M-$126M-$111M-$106M-$99M-$121M-$121M-$129M-$133M
Interest income$13.9M$14.9M$13.9M$13.3M$11.7M$9.11M$7.56M$7.39M$10M$11.2M$10.2M$9.75M
Interest expense$645K$645K$645K$646K$645K$791K$983K$943K$1.18M$1.35M$1.35M$1.35M
Other non-operating income (gains on investments, FX ...)-$10.6M$14.3M$1.23M-$10.3M-$16.3M-$17M-$7.54M-$7.34M$8.24M-$11M-$10.5M-$10.1M
Total non-operating income$9.93M-$14.9M-$1.88M$9.6M$15.7M$16.2M$6.55M$6.4M-$9.42M$9.65M$9.16M$8.75M
Income before tax-$188M-$115M-$102M-$108M-$110M-$94.9M-$99.9M-$92.6M-$130M-$112M-$120M-$124M
Income tax-$541K$405K$133K$30K$716K$290K$38K$136K-$1.73M$372K$185K$343K
Net income-$187M-$115M-$103M-$108M-$111M-$95.2M-$99.9M-$92.7M-$128M-$112M-$120M-$124M
EPS (basic)-$1.58-$0.94-$0.84-$0.88-$0.90-$0.77-$0.80-$0.74-$1.00-$0.85-$0.90-$0.93
EPS (diluted)-$1.58-$0.94-$0.84-$0.88-$0.90-$0.77-$0.80-$0.74-$1.00-$0.85-$0.90-$0.93
Shares (basic, weighted)119M122M122M123M124M124M124M125M129M131M132M134M
Shares (diluted, weighted)119M122M122M123M124M124M124M125M129M131M132M134M
Depreciation & amortization$10.9M$10.7M$10.6M$10.6M$10.5M$10.2M$10M$9.41M$10.1M$9.44M$9.56M$10.2M
EBITDA-$176M-$103M-$91.2M-$96.5M-$99.2M-$83.8M-$88.8M-$82.2M-$119M-$101M-$109M-$112M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Revenue, operating income and growth

quarterly

Margins

quarterly

Costs as % of revenue

quarterly

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

Data as of 2026-11-22